United States: Varian ─ Challenging the validity of tax regulations after Loper Bright

Tax News and Developments October 2024

In brief

On August 26, 2024, the US Tax Court held in Varian Medical Systems Inc. v. Commissioner that a taxpayer is entitled to the section 245A dividends-received deduction for the section 78 dividends that arose in connection with the section 965 transition tax. The Court also held that section 245A(d)(1) partially disallows certain foreign tax credits (FTCs) on the amounts that are deducted under section 245A. This case provided the first opportunity for the Tax Court to apply the Supreme Court's decision in Loper Bright Enterprises v. Raimondo, which overruled agency deference established in Chevron, U.S.A., Inc. v. Natural Resources Defense Council, Inc., 467 U.S. 837 (1984).


Contents

Background

As part of the Tax Cuts and Jobs Act (TCJA), Congress added section 245A, which provides a deduction for the foreign-source portion of any dividend received by a US shareholder from the shareholder’s specified 10-percent owned foreign corporation. Before amendment by the TCJA, section 78 (“Old Section 78”) provided that if a domestic corporation claimed foreign tax credits for any taxable year under section 902 and section 960(a)(1), an amount equal to the taxes deemed paid by such corporation for such taxable year “shall be treated” for purposes of the Code (except section 245) as a dividend received by such domestic corporation from the foreign corporation. After amendment by the TCJA, section 78 (“New Section 78”) provides that an amount equal to the foreign taxes paid under section 960(a) shall be treated for purposes of the Code (except section 245 and section 245A) as dividends received by the domestic corporation from the foreign corporation whose taxes are deemed paid. Section 245A applied to distributions made after December 31, 2017. New Section 78 applied to “taxable years of foreign corporations beginning after December 31, 2017, and... taxable years of United States shareholders in which or with which such taxable years of foreign corporations end." 

The taxpayer in this case, Varian Medical Systems, and its controlled foreign corporations (CFCs) were fiscal-year taxpayers. For the taxable year at issue, Varian's taxable year started on September 30, 2017, and ended on September 28, 2018 (“FY18”). During this taxable year, Varian elected to claim FTCs for foreign taxes that it was deemed to pay under section 960 and was therefore required to treat an amount equal to the foreign taxes paid as a dividend under section 78. During Varian’s FY18 taxable year, section 245A applied at the same time as Old Section 78. Accordingly, based on the unambiguous statutory effective dates and the overlapping application of section 245A and Old Section 78, Varian claimed a deduction under section 245A for the section 78 dividends from its specified foreign corporations.

To override the TCJA’s unambiguous statutory effective dates, Treasury and the IRS issued Treas. Reg. § 1.78-1(a), which provides, in pertinent part, that “[a] section 78 dividend is treated as a dividend for all purposes of the Code, except that it is not treated as a dividend for purposes of section 245 or 245A, and does not increase the earnings and profits of the domestic corporation or decrease the earnings and profits of the foreign corporation”. Treas. Reg. § 1.78-1(c) states that this provision “applies to section 78 dividends that are received after December 31, 2017, by reason of taxes deemed paid under section 960(a) with respect to a taxable year of a foreign corporation beginning before January 1, 2018.” Thus, the regulatory effective date in the second sentence of Treas. Reg. § 1.78-1(c) contradicts the TCJA’s unambiguous statutory effective dates (described above). 

The IRS audited Varian’s tax return and issued a Notice of Deficiency. The IRS disallowed Varian's claimed deduction under section 245A for its section 78 dividend. In the alternative, the IRS determined that if Varian was in fact entitled to deduct its section 78 dividend under section 245A, then section 245A(d) would partially disallow foreign tax credits attributable to that amount.

Analysis

The central issue in this case involved the attempt by Treasury and the IRS to override the unambiguous statutory effective dates in the TCJA. Applying Loper Bright, the Court determined that the best reading of the operative statutes meant that Varian could claim a dividends-received deduction under section 245A for the section 78 dividend that arose in connection with Varian’s section 965 transition tax. The Court also concluded that section 245A(d) applies to disallow a portion of the deemed paid taxes as an FTC.

Implications

Fiscal-year taxpayers who claimed foreign tax credits in connection with their section 965 transition tax should consider the potential to file a refund claim based on the application of the Tax Court’s opinion in Varian to their facts.    


Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.